AKBA
Akebia Ther
NASDAQ: AKBA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.93
-4.84% today
Updated 2026-09-23
Market cap
$271.56M
P/E ratio
—
P/S ratio
1.24x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$1 – $3
Volume
6.3M
Akebia Ther (AKBA) Insider transactions
Net insider activity
Net buying (9,690,626 shares)
Buy transactions
69
Sell transactions
31
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-29 | OSTROWSKI, ERIK | SVP, CFO, CBO & Treasurer | Sale | 56,019 | $1.11 | $62181.09 |
| 2026-06-17 | ZUMWALT, LEANNE M | Director | Buy | 53,600 | — | — |
| 2026-06-17 | ZUMWALT, LEANNE M | Director | Buy | 35,700 | — | — |
| 2026-06-17 | WOLF, MYLES | Director | Buy | 53,600 | — | — |
| 2026-06-17 | WOLF, MYLES | Director | Buy | 35,700 | — | — |
| 2026-06-17 | SMITH, CYNTHIA | Director | Buy | 53,600 | — | — |
| 2026-06-17 | SMITH, CYNTHIA | Director | Buy | 35,700 | — | — |
| 2026-06-17 | ROGERS, MICHAEL W | Director | Buy | 53,600 | — | — |
| 2026-06-17 | ROGERS, MICHAEL W | Director | Buy | 35,700 | — | — |
| 2026-06-17 | FRIESON, RON | Director | Buy | 53,600 | — | — |
| 2026-06-17 | FRIESON, RON | Director | Buy | 35,700 | — | — |
| 2026-06-17 | ADAMS, ADRIAN | Director | Buy | 53,600 | — | — |
| 2026-06-17 | ADAMS, ADRIAN | Director | Buy | 35,700 | — | — |
| 2026-04-01 | VICKERS, PHILIP J. | Director | Buy | 214,400 | — | — |
| 2026-03-04 | BUTLER, JOHN P. | Director, CEO and President | Buy | 69,270 | $1.25 | $86587.50 |
| 2026-02-02 | RUCCI, CAROLYN M. | SVP, Chief Legal Officer | Sale | 27,544 | $1.39 | $38286.16 |
| 2026-02-02 | RUCCI, CAROLYN M. | SVP, Chief Legal Officer | Sale | 25,382 | $1.39 | $35280.98 |
| 2026-02-02 | RUCCI, CAROLYN M. | SVP, Chief Legal Officer | Sale | 16,846 | $1.39 | $23415.94 |
| 2026-02-02 | OSTROWSKI, ERIK | SVP, CFO, CBO & Treasurer | Sale | 34,951 | $1.39 | $48581.89 |
| 2026-02-02 | MALABRE, RICHARD C | SVP, Chief Accounting Officer | Sale | 36,142 | $1.39 | $50237.38 |
| 2026-02-02 | MALABRE, RICHARD C | SVP, Chief Accounting Officer | Sale | 13,382 | $1.39 | $18600.98 |
| 2026-02-02 | GRUND, NICHOLAS | Chief Commercial Officer | Sale | 53,585 | $1.39 | $74483.15 |
| 2026-02-02 | GRUND, NICHOLAS | Chief Commercial Officer | Sale | 31,244 | $1.39 | $43429.16 |
| 2026-02-02 | BUTLER, JOHN P. | Director, CEO and President | Buy | 175,250 | $1.41 | $247102.50 |
| 2026-02-02 | BUTLER, JOHN P. | Director, CEO and President | Sale | 114,891 | $1.39 | $159698.49 |
| 2026-02-02 | BUTLER, JOHN P. | Director, CEO and President | Sale | 96,065 | $1.39 | $133530.35 |
| 2026-02-02 | BUTLER, JOHN P. | Director, CEO and President | Sale | 83,689 | $1.39 | $116327.71 |
| 2026-02-02 | BUTLER, JOHN P. | Director, CEO and President | Sale | 46,660 | $1.39 | $64857.40 |
| 2026-02-02 | BURKE, STEVEN KEITH | SVP, Chief Medical Officer | Sale | 25,375 | $1.39 | $35271.25 |
| 2026-02-02 | BURKE, STEVEN KEITH | SVP, Chief Medical Officer | Sale | 21,582 | $1.39 | $29998.98 |
| 2026-02-02 | BURKE, STEVEN KEITH | SVP, Chief Medical Officer | Sale | 20,701 | $1.39 | $28774.39 |
| 2026-01-30 | RUCCI, CAROLYN M. | SVP, Chief Legal Officer | Buy | 270,000 | — | — |
| 2026-01-30 | RUCCI, CAROLYN M. | SVP, Chief Legal Officer | Buy | 190,000 | — | — |
| 2026-01-30 | OSTROWSKI, ERIK | SVP, CFO, CBO & Treasurer | Buy | 320,000 | — | — |
| 2026-01-30 | OSTROWSKI, ERIK | SVP, CFO, CBO & Treasurer | Buy | 204,000 | — | — |
| 2026-01-30 | MALABRE, RICHARD C | SVP, Chief Accounting Officer | Buy | 119,000 | — | — |
| 2026-01-30 | MALABRE, RICHARD C | SVP, Chief Accounting Officer | Buy | 79,000 | — | — |
| 2026-01-30 | GRUND, NICHOLAS | Chief Commercial Officer | Buy | 320,000 | — | — |
| 2026-01-30 | GRUND, NICHOLAS | Chief Commercial Officer | Buy | 204,000 | — | — |
| 2026-01-30 | BUTLER, JOHN P. | Director, CEO and President | Buy | 1,115,000 | — | — |
| 2026-01-30 | BUTLER, JOHN P. | Director, CEO and President | Buy | 743,000 | — | — |
| 2026-01-30 | BURKE, STEVEN KEITH | SVP, Chief Medical Officer | Buy | 320,000 | — | — |
| 2026-01-30 | BURKE, STEVEN KEITH | SVP, Chief Medical Officer | Buy | 204,000 | — | — |
| 2025-06-30 | OSTROWSKI, ERIK | SVP, CFO, CBO & Treasurer | Sale | 41,314 | $3.67 | $151622.38 |
| 2025-06-10 | ZUMWALT, LEANNE M | Director | Buy | 53,600 | — | — |
| 2025-06-10 | ZUMWALT, LEANNE M | Director | Buy | 35,700 | — | — |
| 2025-06-10 | WOLF, MYLES | Director | Buy | 53,600 | — | — |
| 2025-06-10 | WOLF, MYLES | Director | Buy | 35,700 | — | — |
| 2025-06-10 | SMITH, CYNTHIA | Director | Buy | 53,600 | — | — |
| 2025-06-10 | SMITH, CYNTHIA | Director | Buy | 35,700 | — | — |
| 2025-06-10 | ROGERS, MICHAEL W | Director | Buy | 53,600 | — | — |
| 2025-06-10 | ROGERS, MICHAEL W | Director | Buy | 35,700 | — | — |
| 2025-06-10 | GILMAN, STEVEN C | Director | Buy | 53,600 | — | — |
| 2025-06-10 | GILMAN, STEVEN C | Director | Buy | 35,700 | — | — |
| 2025-06-10 | FRIESON, RON | Director | Buy | 53,600 | — | — |
| 2025-06-10 | FRIESON, RON | Director | Buy | 35,700 | — | — |
| 2025-06-10 | ADAMS, ADRIAN | Director | Buy | 53,600 | — | — |
| 2025-06-10 | ADAMS, ADRIAN | Director | Buy | 35,700 | — | — |
| 2025-06-09 | MALABRE, RICHARD C | SVP, Chief Accounting Officer | Sale | 15,000 | — | — |
| 2025-06-09 | MALABRE, RICHARD C | SVP, Chief Accounting Officer | Sale | 15,000 | $4.01 | $60150.00 |
| 2025-06-04 | MALABRE, RICHARD C | SVP, Chief Accounting Officer | Sale | 13,334 | $3.53 | $47069.02 |
| 2025-03-03 | BUTLER, JOHN P. | Director, CEO and President | Sale | 46,409 | $1.83 | $84928.47 |
| 2025-03-03 | BURKE, STEVEN KEITH | SVP, Chief Medical Officer | Sale | 7,144 | $1.83 | $13073.52 |
| 2025-02-03 | MALABRE, RICHARD C | SVP, Chief Accounting Officer | Sale | 30,202 | $2.10 | $63424.20 |
| 2025-02-03 | GRUND, NICHOLAS | Chief Commercial Officer | Sale | 55,621 | $2.10 | $116804.10 |
| 2025-02-03 | BUTLER, JOHN P. | Director, CEO and President | Sale | 97,982 | $2.10 | $205762.20 |
| 2025-02-03 | BUTLER, JOHN P. | Director, CEO and President | Sale | 46,268 | $2.10 | $97162.80 |
| 2025-02-03 | BURKE, STEVEN KEITH | SVP, Chief Medical Officer | Sale | 27,236 | $2.10 | $57195.60 |
| 2025-02-03 | BURKE, STEVEN KEITH | SVP, Chief Medical Officer | Sale | 23,270 | $2.10 | $48867.00 |
| 2025-01-31 | OSTROWSKI, ERIK | SVP, CFO, CBO & Treasurer | Buy | 292,300 | — | — |
| 2025-01-31 | OSTROWSKI, ERIK | SVP, CFO, CBO & Treasurer | Buy | 194,900 | — | — |
| 2025-01-31 | MALABRE, RICHARD C | SVP, Chief Accounting Officer | Buy | 128,000 | — | — |
| 2025-01-31 | MALABRE, RICHARD C | SVP, Chief Accounting Officer | Buy | 85,000 | — | — |
| 2025-01-31 | GRUND, NICHOLAS | Chief Commercial Officer | Buy | 292,300 | — | — |
| 2025-01-31 | GRUND, NICHOLAS | Chief Commercial Officer | Buy | 194,900 | — | — |
| 2025-01-31 | BUTLER, JOHN P. | Director, CEO and President | Buy | 1,051,400 | — | — |
| 2025-01-31 | BUTLER, JOHN P. | Director, CEO and President | Buy | 350,500 | — | — |
| 2025-01-31 | BUTLER, JOHN P. | Director, CEO and President | Buy | 701,000 | — | — |
| 2025-01-31 | BURKE, STEVEN KEITH | SVP, Chief Medical Officer | Buy | 292,300 | — | — |
| 2025-01-31 | BURKE, STEVEN KEITH | SVP, Chief Medical Officer | Buy | 194,900 | — | — |
| 2025-01-17 | FRIESON, RON | Director | Sale | 20,100 | — | — |
| 2025-01-17 | FRIESON, RON | Director | Buy | 20,100 | $0.45 | $9045.00 |
| 2024-06-28 | OSTROWSKI, ERIK | SVP, CFO, CBO & Treasurer | Buy | 500,000 | — | — |
| 2024-06-28 | OSTROWSKI, ERIK | SVP, CFO, CBO & Treasurer | Buy | 350,000 | — | — |
| 2024-06-06 | ZUMWALT, LEANNE M | Director | Buy | 45,000 | — | — |
| 2024-06-06 | ZUMWALT, LEANNE M | Director | Buy | 30,000 | — | — |
| 2024-06-06 | WOLF, MYLES | Director | Buy | 45,000 | — | — |
| 2024-06-06 | WOLF, MYLES | Director | Buy | 30,000 | — | — |
| 2024-06-06 | SMITH, CYNTHIA | Director | Buy | 45,000 | — | — |
| 2024-06-06 | SMITH, CYNTHIA | Director | Buy | 30,000 | — | — |
| 2024-06-06 | ROGERS, MICHAEL W | Director | Buy | 45,000 | — | — |
| 2024-06-06 | ROGERS, MICHAEL W | Director | Buy | 30,000 | — | — |
| 2024-06-06 | GILMAN, STEVEN C | Director | Buy | 45,000 | — | — |
| 2024-06-06 | GILMAN, STEVEN C | Director | Buy | 30,000 | — | — |
| 2024-06-06 | FRIESON, RON | Director | Buy | 45,000 | — | — |
| 2024-06-06 | FRIESON, RON | Director | Buy | 30,000 | — | — |
| 2024-06-06 | ADAMS, ADRIAN | Director | Buy | 45,000 | — | — |
| 2024-06-06 | ADAMS, ADRIAN | Director | Buy | 30,000 | — | — |
| 2024-05-13 | HADAS, NICOLE R. | SVP, Chief Legal Officer | Sale | 12,016 | $1.26 | $15140.16 |
| 2024-05-13 | DAHAN, MICHEL | SVP, Chief Operating Officer | Sale | 34,840 | $1.26 | $43898.40 |
Frequently asked questions
Are AKBA insiders buying or selling?
Over the transactions on record, AKBA insiders have been net buyers, with about $1.97M in stock sold across 31 sales, against 3 open-market purchases.
Does insider selling at AKBA mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which AKBA insiders are selling the most?
Recent selling is concentrated in a few names. BUTLER, JOHN P. accounts for the largest share on record, with about $862267.42 sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.